These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quantitative policy analysis and public health policy: a macro and micro view. Hinman AR Am J Prev Med; 1997; 13(1):6-11. PubMed ID: 9037336 [TBL] [Abstract][Full Text] [Related]
5. Buy the premise and you buy the bit. Hage SJ Radiol Manage; 1995; 17(3):12, 14-5. PubMed ID: 10144824 [No Abstract] [Full Text] [Related]
6. On sale: future health care. The paradox of discounting. Ganiats TG West J Med; 1992 May; 156(5):550-3. PubMed ID: 1595287 [No Abstract] [Full Text] [Related]
7. Reducing need and demand. Fries JF Healthc Forum J; 1993; 36(6):18-23. PubMed ID: 10129746 [No Abstract] [Full Text] [Related]
8. Analysis of prevention benefits in comprehensive health care reform legislation in the 102nd Congress. Schauffler HH Am J Prev Med; 1994; 10(1):45-51. PubMed ID: 8172731 [TBL] [Abstract][Full Text] [Related]
9. Aging diseases--do they prevent preventive health care from saving costs? Gandjour A Health Econ; 2009 Mar; 18(3):355-62. PubMed ID: 18833543 [TBL] [Abstract][Full Text] [Related]
10. Using cost-effectiveness/cost-benefit analysis to allocate health resources: a level playing field for prevention? Phillips KA; Hotlgrave DR Am J Prev Med; 1997; 13(1):18-25. PubMed ID: 9037338 [TBL] [Abstract][Full Text] [Related]
11. Prevention, policy, and paradox: what is the value of future health? Ganiats TG Am J Prev Med; 1997; 13(1):12-7. PubMed ID: 9037337 [TBL] [Abstract][Full Text] [Related]
12. Free care, cholestyramine, and health policy. Himmelstein DU; Woolhandler S N Engl J Med; 1984 Dec; 311(23):1511-4. PubMed ID: 6438506 [No Abstract] [Full Text] [Related]
13. Valuing prevention: discounting health benefits and costs in New Zealand. Milne R N Z Med J; 2005 May; 118(1214):U1443. PubMed ID: 15886738 [No Abstract] [Full Text] [Related]
14. Why not try preventing illness as a way of controlling Medicare costs? Somers AR N Engl J Med; 1984 Sep; 311(13):853-6. PubMed ID: 6433199 [No Abstract] [Full Text] [Related]
15. Is high and growing spending on cancer treatment and prevention harmful to the United States economy? Pauly MV J Clin Oncol; 2007 Jan; 25(2):171-4. PubMed ID: 17210935 [No Abstract] [Full Text] [Related]
16. Preventive services and medical care: the costs and benefits of basic change. Terris M Bull N Y Acad Med; 1980; 56(1):180-8. PubMed ID: 6766761 [No Abstract] [Full Text] [Related]
17. [Health policy--prevention rarely pays. Interview by Mette Fjordbo]. Alban A Sygeplejersken; 1993 Mar; 93(13):22-3. PubMed ID: 8211725 [No Abstract] [Full Text] [Related]
18. The president's fiscal year 2007 initiative for human immunodeficiency virus counseling and testing expansion in the United States: a scenario analysis of its coverage, impact, and cost-effectiveness. Holtgrave DR J Public Health Manag Pract; 2007; 13(3):239-43. PubMed ID: 17435490 [TBL] [Abstract][Full Text] [Related]
19. The economics of prevention: does it save money? Mirvis DM; Chang CF Tenn Med; 2004 Nov; 97(11):495-6, 498. PubMed ID: 15620201 [No Abstract] [Full Text] [Related]
20. The costs and benefits of prevention. J Public Health Policy; 1980 Dec; 1(4):285-92. PubMed ID: 6788800 [No Abstract] [Full Text] [Related] [Next] [New Search]